Drug profile · INN
ziprasidone hydrochloride
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride (ZIPRASIDONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — ziprasidone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ziprasidone hydrochloride (ZIPRASIDONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ziprasidone hydrochloride?
ziprasidone hydrochloride (ZIPRASIDONE HYDROCHLORIDE) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ziprasidone hydrochloride?
ZIPRASIDONE HYDROCHLORIDE is a marketed brand name for ziprasidone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ziprasidone hydrochloride?
ziprasidone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.